Ekiz Kimya Sanayi ve Ticaret A.S.

As of June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. carries a market capitalization of 2.66M, placing it among publicly traded companies globally. Its enterprise value stands at 27.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. has 7.18M shares outstanding.

These figures are as of June 30, 2013. The price-to-sales ratio is 0.08, and the price-to-book ratio stands at 1.52.

As of June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. trades at an EV/EBITDA multiple of 46.86 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.80 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 27.82M versus a market cap of 2.66M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. maintains a current ratio of 0.99, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. posted a negative return on equity (ROE) of -43.24, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -8.98, reflecting losses generated across the asset base. The company generates approximately 739,572.70 in revenue per employee across its workforce of 47.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.33 indicates how many times Ekiz Kimya Sanayi ve Ticaret A.S. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. recorded 114,102.00 in income tax expense. The company reported a pretax loss of -3.51M and -3.62M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Ekiz Kimya Sanayi ve Ticaret A.S.'s stock has declined approximately 57.71% over the past 52 weeks. The 50-day moving average sits at 53.42, while the 200-day moving average is 86.78.

Over the twelve months ended June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. generated 34.76M in revenue and converted that into -3.62M in net income, yielding earnings per share of -0.50. EBITDA reached 593,663.00, while operating income came in at -13,457.00.

As of June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. holds 39,390.00 in cash and equivalents against 25.20M in total debt, resulting in a net debt position of 25.16M. Total book value stands at 1.75M, with working capital of -86,761.00 providing operational flexibility.

Ekiz Kimya Sanayi ve Ticaret A.S. produced 229,685.00 in operating cash flow over the twelve months ended June 30, 2013. After subtracting -361,631.00 in capital expenditures, free cash flow totaled -131,946.00 - equivalent to -0.02 per share.

Over the twelve months ended June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. posted a gross margin of 16.42, reflecting its pricing power and cost economics. The operating margin of -0.04 and net profit margin of -10.42 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2013. Free cash flow yield is negative at -4.97: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 12.89, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ekiz Kimya Sanayi ve Ticaret A.S. shareholders.

As of June 30, 2013, Ekiz Kimya Sanayi ve Ticaret A.S. has an Altman Z-Score of -0.02, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.